Norepinephrine is Primarily a Vasopressor; Dobutamine is Primarily an Inotrope
Norepinephrine functions as a vasopressor with some inotropic effects, while dobutamine is classified as an inotrope that may cause vasodilation. This distinction is critical for appropriate drug selection in shock states.
Norepinephrine: Vasopressor with Secondary Inotropic Properties
Norepinephrine is the first-choice vasopressor for shock management 1. Its primary mechanism involves α-adrenergic receptor stimulation causing vasoconstriction and increased systemic vascular resistance, which raises blood pressure 2.
Key Characteristics:
- Primary effect: Increases blood pressure through vasoconstriction
- Secondary effects: Has some β1-adrenergic activity that can increase stroke volume and coronary blood flow, though these positive cardiac effects are often transient 2
- Cardiac output effects: Inconsistent and time-dependent, may unmask underlying myocardial depression by increasing afterload 2
- Heart rate: Direct positive chronotropic effects are typically counterbalanced by vagal reflex from increased blood pressure 2
The 2013 Surviving Sepsis Campaign guidelines explicitly recommend norepinephrine as the first-choice vasopressor (Grade 1B) 1, and contemporary practice data from 2022-2024 show norepinephrine is used in 64.7% of cardiogenic shock cases 3.
Dobutamine: Pure Inotrope with Vasodilatory Properties
Dobutamine is classified under the "Inotropes" section in guidelines and is used specifically for myocardial depression 2, 1. The FDA label describes it as "a direct-acting inotropic agent whose primary activity results from stimulation of the β receptors of the heart" 4.
Key Characteristics:
- Primary effect: Increases cardiac contractility and cardiac output through β1-receptor stimulation 4
- Vascular effects: Decreases systemic and pulmonary vascular resistance (vasodilation, not vasoconstriction) 2
- Blood pressure: Usually maintained or improved only through increased cardiac output; can cause hypotension in low systemic vascular resistance states 2
- Heart rate: Produces comparatively mild chronotropic effects compared to other inotropes 4
The Surviving Sepsis guidelines recommend dobutamine infusion (up to 20 mcg/kg/min) specifically for myocardial dysfunction with low cardiac output or ongoing hypoperfusion despite adequate volume and MAP 1.
Clinical Algorithm for Drug Selection
For hypotension with adequate cardiac output:
- Use norepinephrine as first-line vasopressor 1
- Target MAP ≥65 mmHg
For low cardiac output with adequate blood pressure:
For combined hypotension AND low cardiac output:
- Start norepinephrine first to restore perfusion pressure
- Add dobutamine if tissue perfusion remains inadequate despite adequate MAP 1, 7
Common Pitfall to Avoid
Do not confuse norepinephrine's mild inotropic effects with its primary classification. While norepinephrine can increase stroke volume through β2-receptor stimulation of coronary vessels 2, this does not make it an inotrope. Its predominant α-adrenergic vasoconstrictive effects and guideline-designated role as a vasopressor clearly distinguish it from true inotropes like dobutamine.
Similarly, dobutamine's vasodilatory effects do not make it a vasopressor—it actually decreases vascular resistance and can worsen hypotension in vasodilatory shock 2. Recent trial data confirm that combining dobutamine with norepinephrine (rather than using dobutamine alone) improves outcomes in septic shock patients undergoing surgery 8.